2Cheung BMY, Lan CP. Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial[J]. Br J Clin Pharmacol, 1999,47: 179 - 187
6Koren MJ. Relation of left ventricular mass and geometry to morbidity and movtality in uncomplicated essential hypertension [ J]. Am Intern Med, 1999, 114 : 345
二级参考文献12
1Zhang W，Circulation Research，1999年，84卷，722页
2Molkentin J D，Cell，1998年，93卷，215页
3Fraccarollo D，Circulation，1997年，96卷，3963页
4Yamazaki Y，Circulation，1997年，95卷，1260页
5Cheung B M Y，Br J Clin Pharmacol，1999年，47卷，179页
6Meguro T，Circulation Research，1999年，84卷，735页
7Brilla C G，J Am Coll Cardiol，1994年，26卷，809页
8Koren MJ.Relation of left Ventricular mass and geometry to morbidity and movtality in uncomplicated essential hypertension Am Intern Med 1999,114:345
9Devereux R B.Pickering T G,Alder man MH, et al,left ventricular hypertrophy in hypertension Prevalence and relationship to pathophysiology.Hypertension 1997,9(suppl):53
10Levy D,Anderson K M,Savage DD, et al.Risk of ventricular arrhythmious in left vetricular hypertroply:The framinngham heart study Am I Cardiol 1997,60:560
5Kereiakes DJ.Reassessing the importance of complete versus incomplete coronary revascularization[J].Rev Cardiovasc Med,2014,15(1):24-30.
6翁明翰,陈珠.活心丹治疗缺血型心脏病疗效观察[J].广东医学,1982,3(10):29-31.
7Kalra DK,Zoghbi WA.Myocardial hibernation in coronary artery disease[J].Curr Atheroscler Rep,2002,4(2):149-155.
8Bukachi F,Clague JR,Waldenstrm A,et al.Clinical outcome of coronary angioplasty in patients with ischaemic cardiomyopathy[J].Int J Cardiol,2003,88(2-3):167-174.
9Hobbs FD,Roalfe AK,Davis RC,et al.Prognosis of all case heart failure and borderling left ventricular systolic dysfunction:5-year mortality follow-up of the Echocardiographic Heart of England Screening Study(ECHOES)[J].Eur Heart J,2007,28(9):1128-1134.
10Jedrzkiewicz S,Goodman SG,Yan RT,et al.Evaluation of left ventricular ejection in non-ST-segment elevation acute coronary syndromes and its relationship to treatment[J].Am Heart J,2010,159(4):605-611.
